130 related articles for article (PubMed ID: 12550114)
21. Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27(kip1) levels.
D'Agnano I; Valentini A; Fornari C; Bucci B; Starace G; Felsani A; Citro G
Oncogene; 2001 May; 20(22):2814-25. PubMed ID: 11420693
[TBL] [Abstract][Full Text] [Related]
22. Reduction of c-myc expression by an antisense approach under Cre/loxP switching induces apoptosis in human liver cancer cells.
Ebinuma H; Saito H; Kosuga M; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Okuyama T; Ishii H
J Cell Physiol; 2001 Jul; 188(1):56-66. PubMed ID: 11382922
[TBL] [Abstract][Full Text] [Related]
23. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
Ginobbi P; Geiser TA; Ombres D; Citro G
Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
[TBL] [Abstract][Full Text] [Related]
24. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
25. Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines.
Cerutti J; Trapasso F; Battaglia C; Zhang L; Martelli ML; Visconti R; Berlingieri MT; Fagin JA; Santoro M; Fusco A
Clin Cancer Res; 1996 Jan; 2(1):119-26. PubMed ID: 9816098
[TBL] [Abstract][Full Text] [Related]
26. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU
Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316
[TBL] [Abstract][Full Text] [Related]
27. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.
Watson PH; Pon RT; Shiu RP
Cancer Res; 1991 Aug; 51(15):3996-4000. PubMed ID: 1855215
[TBL] [Abstract][Full Text] [Related]
29. Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides.
Hegyesi H; Somlai B; Varga VL; Toth G; Kovacs P; Molnar EL; Laszlo V; Karpati S; Rivera E; Falus A; Darvas Z
J Invest Dermatol; 2001 Jul; 117(1):151-3. PubMed ID: 11442763
[TBL] [Abstract][Full Text] [Related]
30. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.
Lin X; Sun R; Zhao X; Zhu D; Zhao X; Gu Q; Dong X; Zhang D; Zhang Y; Li Y; Sun B
J Mol Med (Berl); 2017 Jan; 95(1):53-67. PubMed ID: 27543492
[TBL] [Abstract][Full Text] [Related]
31. Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma.
Ricaniadis N; Kataki A; Agnantis N; Androulakis G; Karakousis CP
Eur J Surg Oncol; 2001 Feb; 27(1):88-93. PubMed ID: 11237497
[TBL] [Abstract][Full Text] [Related]
32. Silencing of human c-myc oncogene expression by poly-DNP-RNA.
Shen L; Zhang C; Ambrus JL; Wang JH
Oligonucleotides; 2005; 15(1):23-35. PubMed ID: 15788898
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
[TBL] [Abstract][Full Text] [Related]
34. The clinical significance of oncogene expression in subungual melanoma.
Grover R; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R
Br J Plast Surg; 1997 Jan; 50(1):15-9. PubMed ID: 9038509
[TBL] [Abstract][Full Text] [Related]
35. Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma.
Grover R; Ross DA; Wilson GD; Sanders R
Br J Plast Surg; 1997 Oct; 50(7):478-82. PubMed ID: 9422944
[TBL] [Abstract][Full Text] [Related]
36. Antisense c-myc fragments induce normal differentiation cycles in HL-60 cells.
Chen JP; Chen L; Leek J; Lin C
Eur J Clin Invest; 2006 Jan; 36(1):49-57. PubMed ID: 16403010
[TBL] [Abstract][Full Text] [Related]
37. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma.
Blom DJ; Mooy CM; Luyten GP; Kerkvliet S; Ouwerkerk I; Zwinderman AH; Schrier PI; Jager MJ
J Pathol; 1997 Jan; 181(1):75-9. PubMed ID: 9072006
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells.
Shi Y; Hutchinson HG; Hall DJ; Zalewski A
Circulation; 1993 Sep; 88(3):1190-5. PubMed ID: 8353880
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line.
Welch DR; Bisi JE; Miller BE; Conaway D; Seftor EA; Yohem KH; Gilmore LB; Seftor RE; Nakajima M; Hendrix MJ
Int J Cancer; 1991 Jan; 47(2):227-37. PubMed ID: 1671030
[TBL] [Abstract][Full Text] [Related]
40. c-myc is not useful as prognostic immunohistochemical marker in cutaneous melanoma.
Böni R; Bantschapp O; Müller B; Burg G
Dermatology; 1998; 196(3):288-91. PubMed ID: 9621133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
